Univariate outcome probabilities
. | Type of transplant, probability, % (95% CI) . | . | . | ||
|---|---|---|---|---|---|
| Outcomes . | HLA-identical sibling . | Autologous purged . | Autologous unpurged . | ||
| Treatment-related mortality* | |||||
| 1 y | 24 (18-32) | 8 (5-15) | 4 (3-6) | ||
| 3 y | 28 (21-36) | 10 (6-17) | 6 (4-8) | ||
| 5 y | 30 (23-40) | 14 (8-22) | 8 (6-11) | ||
| Relapse* | |||||
| 1 y | 19 (14-26) | 25 (18-34) | 36 (32-40) | ||
| 3 y | 21 (15-28) | 40 (32-50) | 52 (48-57) | ||
| 5 y | 21 (15-28) | 43 (35-54) | 58 (53-63) | ||
| Disease-free survival† | |||||
| 1 y | 55 (48-62) | 66 (58-74) | 59 (55-63) | ||
| 3 y | 48 (40-55) | 48 (39-57) | 41 (37-45) | ||
| 5 y | 45 (36-53) | 39 (30-48) | 31 (27-36) | ||
| Overall survival† | |||||
| 1 y | 61 (54-68) | 82 (76-89) | 81 (78-84) | ||
| 3 y | 54 (47-62) | 71 (63-79) | 65 (61-69) | ||
| 5 y | 51 (43-60) | 62 (53-72) | 55 (50-60) | ||
. | Type of transplant, probability, % (95% CI) . | . | . | ||
|---|---|---|---|---|---|
| Outcomes . | HLA-identical sibling . | Autologous purged . | Autologous unpurged . | ||
| Treatment-related mortality* | |||||
| 1 y | 24 (18-32) | 8 (5-15) | 4 (3-6) | ||
| 3 y | 28 (21-36) | 10 (6-17) | 6 (4-8) | ||
| 5 y | 30 (23-40) | 14 (8-22) | 8 (6-11) | ||
| Relapse* | |||||
| 1 y | 19 (14-26) | 25 (18-34) | 36 (32-40) | ||
| 3 y | 21 (15-28) | 40 (32-50) | 52 (48-57) | ||
| 5 y | 21 (15-28) | 43 (35-54) | 58 (53-63) | ||
| Disease-free survival† | |||||
| 1 y | 55 (48-62) | 66 (58-74) | 59 (55-63) | ||
| 3 y | 48 (40-55) | 48 (39-57) | 41 (37-45) | ||
| 5 y | 45 (36-53) | 39 (30-48) | 31 (27-36) | ||
| Overall survival† | |||||
| 1 y | 61 (54-68) | 82 (76-89) | 81 (78-84) | ||
| 3 y | 54 (47-62) | 71 (63-79) | 65 (61-69) | ||
| 5 y | 51 (43-60) | 62 (53-72) | 55 (50-60) | ||